Public Sector Pension Investment Board grew its holdings in Cardinal Health, Inc. (NYSE:CAH - Free Report) by 2.1% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 120,017 shares of the company's stock after acquiring an additional 2,484 shares during the period. Public Sector Pension Investment Board owned about 0.05% of Cardinal Health worth $16,535,000 as of its most recent filing with the Securities & Exchange Commission.
Several other institutional investors have also modified their holdings of the business. C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors acquired a new position in shares of Cardinal Health in the first quarter worth $210,000. SouthState Corp grew its stake in shares of Cardinal Health by 11.7% in the first quarter. SouthState Corp now owns 953 shares of the company's stock worth $131,000 after acquiring an additional 100 shares in the last quarter. CCM Investment Group LLC acquired a new position in shares of Cardinal Health in the first quarter worth $2,900,000. Nuveen LLC acquired a new position in shares of Cardinal Health in the first quarter worth $106,065,000. Finally, Aigen Investment Management LP grew its stake in shares of Cardinal Health by 13.0% in the first quarter. Aigen Investment Management LP now owns 27,360 shares of the company's stock worth $3,769,000 after acquiring an additional 3,156 shares in the last quarter. Institutional investors and hedge funds own 87.17% of the company's stock.
Analysts Set New Price Targets
Several equities analysts have commented on the stock. Robert W. Baird boosted their price target on shares of Cardinal Health from $156.00 to $170.00 and gave the stock an "outperform" rating in a research note on Friday, May 2nd. UBS Group restated a "buy" rating on shares of Cardinal Health in a research note on Tuesday. Wall Street Zen downgraded shares of Cardinal Health from a "strong-buy" rating to a "buy" rating in a research note on Saturday, August 2nd. Jefferies Financial Group set a $150.00 target price on shares of Cardinal Health in a research note on Tuesday. Finally, Morgan Stanley reiterated an "overweight" rating on shares of Cardinal Health in a research note on Tuesday. Three investment analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company's stock. Based on data from MarketBeat, Cardinal Health currently has an average rating of "Moderate Buy" and a consensus price target of $158.07.
View Our Latest Report on Cardinal Health
Cardinal Health Price Performance
Shares of CAH opened at $158.07 on Tuesday. Cardinal Health, Inc. has a 1-year low of $100.07 and a 1-year high of $168.44. The stock has a market cap of $37.73 billion, a PE ratio of 24.66, a price-to-earnings-growth ratio of 1.56 and a beta of 0.67. The firm has a fifty day moving average price of $160.10 and a 200 day moving average price of $144.16.
About Cardinal Health
(
Free Report)
Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.
Recommended Stories
Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Cardinal Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cardinal Health wasn't on the list.
While Cardinal Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.